Philippa C Matthews

Biographic Data

ID7765965
NAMEPhilippa C Matthews
GIVEN NAMESPhilippa C
FAMILY NAMEMatthews
SIGNATUREMATTHEWS P C
AFFILIATIONSUniversity College Hospital
ORCID0000-0002-4036-4269
VERIFIEDYes
TOTAL WORKS10
TOTAL CITATIONS0
WORKS AS AUTHOR10
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX0

  • “It would be better for those of us who have the disease not to be ashamed”

    Open AccessLouise O Downs, Juliet Odhiambo et al.ARTICLEPLOS Global Public Health2025

    Chronic hepatitis B infection (CHB) causes over 1 million deaths annually, with a large burden of morbidity and mortality in the WHO-African Region (WHO-AFRO) where

  • Is health, growth and development impaired in children who are Hepatitis B-exposed but uninfected

    Open AccessSheila F Lumley, Elaine Parker et al.ARTICLEPLOS Global Public Health2025

    An estimated 254 million people are living with chronic hepatitis B virus (HBV) infection worldwide. Many infants are born to mothers with HBV but do not themselves acquire the infection. It is unclear whether this exposure to HBV in early life - without the development of active infection - may be associated with adverse outcomes. We propose the term “HBV-exposed uninfected (HBEU)”, drawing parallels with the HIV field which recognises that chil…

  • Infecting minds

    Open AccessKingsley Stephen Orievulu, Sally Frampton et al.ARTICLEBMC Public Health2025

    Exploring what shapes attitudes towards vaccines in communities provides opportunities to understand the reasoning behind how people make decisions about whether to take a vaccine in different geographical and cultural spaces. The exploration of contexts, exposures and circumstances provide insights into perceptions and behaviour. Deeper engagement with local communities is crucial to develop evidence that can inform vaccine interventions. Assump…

  • Pandemic preparedness

    Open AccessSally Frampton, Kingsley Stephen Orievulu et al.ARTICLEFrontiers in Public Health2024

    Whilst many lessons were learned from the COVID-19 pandemic, ongoing reflection is needed to develop and maintain preparedness for future outbreaks. Within the field of infectious disease and public health there remain silos and hierarchies in interdisciplinary work, with the risk that humanities and social sciences remain on the epistemological peripheries. However, these disciplines offer insights, expertise and tools that contribute to underst…

  • Retrospective analysis of hospital electronic health records reveals unseen cases of acute hepatitis with unknown aetiology in adults in Oxfordshire

    Open AccessCedric Tan, Cedric C S Tan et al.ARTICLEBMC Public Health2024

    Our results highlight an increase in AHUA in adults coinciding with the period of the outbreak in children, but not linked to documented HAdV infection. Tracking changes in routinely collected clinical data through EHR could be used to support outbreak surveillance

  • A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya

    Open AccessLouise O Downs, Cori Campbell et al.ARTICLEPLOS Global Public Health2023

    The aim of this systematic review and meta-analysis is to evaluate available prevalence and viral sequencing data representing chronic hepatitis B (CHB) infection in Kenya. More than 20% of the global disease burden from CHB is in Africa, however there is minimal high quality seroprevalence data from individual countries and little viral sequencing data available to represent the continent. We undertook a systematic review of the prevalence and g…

  • Hepatitis B Virus

    Open AccessPhilippa C Matthews, Tongai Maponga et al.ARTICLEPLOS Global Public Health2022

    Hepatitis B virus (HBV) is a blood-borne virus that establishes chronic liver infection, associated with potential complications of cirrhosis and/or hepatocellular carcinoma (HCC). As such, it poses a major threat to global public health, accounting for 300 million chronic infections, and more than 500,000 deaths each year It can also be regarded as a 'syndemic' challenge-namely, as one component of multiple, complex interacting health and social…

  • The global impact of the Covid-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection

    Open AccessCaitlin Pley, Anna L McNaughton et al.ARTICLEBMJ Global Health2021

    The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of interventions with the urgent aim of reducing the public health impact of this virus. However, a wealth of evidence both from high-income and low-income countries is accruing on the broader consequences of such interventions on economic and public health inequalities, as well as on pre-existing programmes targeting endemic pathogens. We provide an overview of the imp…

  • Fair data needed to liberate hepatitis B virus (HBV) from the catch-22 of neglect

    Open AccessPhilippa C MatthewsARTICLEJournal of Global Health2019

  • Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa

    Open AccessJolynne Mokaya, Edward Burn et al.ARTICLEBMC Public Health2019

    Given the long-term health burden for individuals and economic burden for society associated with chronic HBV infection, screening pregnant women and providing tenofovir for all who test HBsAg+ may be a cost-effective strategy for South Africa and other low/middle income settings